Cellectar Short Long Term Debt Total from 2010 to 2024

CLRB Stock  USD 0.30  0.98  76.27%   
Cellectar Biosciences' Short and Long Term Debt Total is decreasing over the years with slightly volatile fluctuation. Short and Long Term Debt Total is expected to dwindle to about 487.8 K. From 2010 to 2024 Cellectar Biosciences Short and Long Term Debt Total quarterly data regression line had arithmetic mean of  601,572 and r-squared of  0.16. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2005-03-31
Previous Quarter
553 K
Current Value
512.8 K
Quarterly Volatility
969 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cellectar Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectar Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 288.9 K, Interest Expense of 363.4 K or Selling General Administrative of 11.3 M, as well as many indicators such as Dividend Yield of 0.46, Days Sales Outstanding of 0.0 or Invested Capital of 0.0. Cellectar financial statements analysis is a perfect complement when working with Cellectar Biosciences Valuation or Volatility modules.
  
Check out the analysis of Cellectar Biosciences Correlation against competitors.
For information on how to trade Cellectar Stock refer to our How to Trade Cellectar Stock guide.

Latest Cellectar Biosciences' Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Cellectar Biosciences over the last few years. It is Cellectar Biosciences' Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectar Biosciences' overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Cellectar Short Long Term Debt Total Regression Statistics

Arithmetic Mean601,572
Geometric Mean244,924
Coefficient Of Variation153.16
Mean Deviation434,758
Median454,091
Standard Deviation921,366
Sample Variance848.9B
Range3.9M
R-Value(0.39)
Mean Square Error772.4B
R-Squared0.16
Significance0.15
Slope(81,144)
Total Sum of Squares11.9T

Cellectar Short Long Term Debt Total History

2024487.8 K
2023553 K
2022603.8 K
2021301.7 K
2020421.6 K
2019527.5 K
2018 2213.0

About Cellectar Biosciences Financial Statements

Cellectar Biosciences stakeholders use historical fundamental indicators, such as Cellectar Biosciences' Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Cellectar Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cellectar Biosciences' assets and liabilities are reflected in the revenues and expenses on Cellectar Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cellectar Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total553 K487.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Cellectar Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cellectar Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cellectar Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cellectar Biosciences Stock:
Check out the analysis of Cellectar Biosciences Correlation against competitors.
For information on how to trade Cellectar Stock refer to our How to Trade Cellectar Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellectar Biosciences. If investors know Cellectar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cellectar Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.41)
Return On Assets
(1.66)
Return On Equity
(7.97)
The market value of Cellectar Biosciences is measured differently than its book value, which is the value of Cellectar that is recorded on the company's balance sheet. Investors also form their own opinion of Cellectar Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Cellectar Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cellectar Biosciences' market value can be influenced by many factors that don't directly affect Cellectar Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cellectar Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cellectar Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellectar Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.